Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

NCT02777775 is registered in ClinicalTrials.gov with Corewell Health West as lead sponsor.

NCT NCT02777775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02777775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
Lead sponsor
Corewell Health West
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
June 30, 2025
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous neurofibromas, neurofibromatosis type 1, plexiform neurofibromas